GSA Capital Partners’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,563
| Closed | -$380K | – | 1995 |
|
|
2022
Q4 | $380K | Buy |
+4,563
| New | +$380K | 0.05% | 784 |
|
|
2021
Q2 | – | Sell |
-979
| Closed | -$201K | – | 1640 |
|
|
2021
Q1 | $201K | Buy |
+979
| New | +$201K | 0.03% | 909 |
|
|
2020
Q3 | – | Sell |
-165
| Closed | -$41K | – | 1418 |
|
|
2020
Q2 | $41K | Sell |
165
-1,772
| -91% | -$440K | 0.02% | 542 |
|
|
2020
Q1 | $353K | Sell |
1,937
-505
| -21% | -$92K | 0.09% | 378 |
|
|
2019
Q4 | $707K | Buy |
+2,442
| New | +$707K | 0.08% | 418 |
|
|
2019
Q3 | – | Sell |
-740
| Closed | -$278K | – | 1760 |
|
|
2019
Q2 | $278K | Sell |
740
-476
| -39% | -$179K | 0.03% | 1047 |
|
|
2019
Q1 | $326K | Sell |
1,216
-268
| -18% | -$71.8K | 0.03% | 945 |
|
|
2018
Q4 | $316K | Sell |
1,484
-2,904
| -66% | -$618K | 0.04% | 812 |
|
|
2018
Q3 | $1.97M | Buy |
4,388
+1,014
| +30% | +$454K | 0.11% | 252 |
|
|
2018
Q2 | $1.37M | Buy |
3,374
+3,165
| +1,514% | +$1.28M | 0.07% | 525 |
|
|
2018
Q1 | $114K | Hold |
209
| – | – | 0.01% | 1523 |
|
|
2017
Q4 | $126K | Buy |
+209
| New | +$126K | 0.01% | 1464 |
|